Morphocell Technologies News and Activities

Acquisition, funding and merger involving Morphocell Technologies.

• Morphocell Technologies has just announced a $50 Million fundraising (posted on December 3 2025).

View the org chart displaying its 8 main executives

Most searched biographies at Morphocell Technologies

• Massimiliano Paganelli, Chief Executive Officer
• Sandra Alves, Chief Financial Officer
• Bruno Marques, Senior Vice President, Technical Operations

Popular executive movements at Morphocell Technologies

• Sandra Alves has joined the company as Chief Financial Officer  (posted on July 8 2026).
• Bruno Marques has joined the company as Senior Vice President, Technical Operations  (posted on March 10 2026).

Create your alert
to follow the executive moves at Morphocell Technologies.

Morphocell Technologies has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Morphocell Technologies

Social media about Morphocell Technologies

• Morphocell Technologies on Wikipedia, Google News & Yahoo Finance
• Morphocell Technologies on LinkedIn, X (Twitter) & YouTube